Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.

about

Do micropapillary patients benefit from chemotherapy?

P2860

Q52777539-F9585E34-EB58-424B-AF25-4C8D3E573431

P2860

Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.

Item

http://www.wikidata.org/entity/Q38983687

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Clinical risk stratification i ...... micropapillary bladder cancer.

@en

type

Item

label

Clinical risk stratification i ...... micropapillary bladder cancer.

@en

prefLabel

Clinical risk stratification i ...... micropapillary bladder cancer.

@en

P1476

Clinical risk stratification i ...... micropapillary bladder cancer

@en

P2093

Arlene O Siefker-Radtke

http://www.w3.org/2001/XMLSchema#string

Ashish M Kamat

http://www.w3.org/2001/XMLSchema#string

Bogdan A Czerniak

http://www.w3.org/2001/XMLSchema#string

Charles C Guo

http://www.w3.org/2001/XMLSchema#string

Colin P N Dinney

http://www.w3.org/2001/XMLSchema#string

Daniel L Willis

http://www.w3.org/2001/XMLSchema#string

David J McConkey

http://www.w3.org/2001/XMLSchema#string

H Barton Grossman

http://www.w3.org/2001/XMLSchema#string

Jay B Shah

http://www.w3.org/2001/XMLSchema#string

Louis L Pisters

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.

Micropapillary bladder cancer: a review of Léon Bérard Cancer Center experience

Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma.

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

Clinical outcomes of cT1 micropapillary bladder cancer.

Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients.

P304

684-691

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJU.13689

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Edmund Chiong

Mario I Fernandez

P577

2016-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27753185

http://www.w3.org/2001/XMLSchema#string

Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.

about

P2860

P2860

Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698